ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
scorpiomo
|
527 |
204K |
3 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
527
|
204K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
scorpiomo
|
215 |
86K |
5 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
215
|
86K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
4 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
2 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
16 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
scorpiomo
|
527 |
204K |
17 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
527
|
204K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
scorpiomo
|
527 |
204K |
0 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
527
|
204K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
scorpiomo
|
551 |
195K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
195K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
scorpiomo
|
536 |
197K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
536
|
197K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
scorpiomo
|
551 |
195K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
195K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
scorpiomo
|
551 |
195K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
195K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
scorpiomo
|
551 |
195K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
195K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
scorpiomo
|
226 |
76K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
76K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
scorpiomo
|
154 |
45K |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
45K
|
2
|
|
ASX - By Stock
|
PLS |
Re:
Ann: Pre-auction Sale
|
|
scorpiomo
|
118 |
61K |
23 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
118
|
61K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
scorpiomo
|
154 |
45K |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
45K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
scorpiomo
|
154 |
45K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
45K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
scorpiomo
|
154 |
45K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
45K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
scorpiomo
|
154 |
45K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
45K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
scorpiomo
|
154 |
45K |
5 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
45K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
scorpiomo
|
549 |
169K |
6 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
549
|
169K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
What happens if there is attempt to take over?
|
|
scorpiomo
|
16 |
5.7K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
16
|
5.7K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
What happens if there is attempt to take over?
|
|
scorpiomo
|
16 |
5.7K |
3 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
16
|
5.7K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
3 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
scorpiomo
|
549 |
169K |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
549
|
169K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
scorpiomo
|
9.4K |
2.7M |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
scorpiomo
|
549 |
169K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
549
|
169K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
3 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
5 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
5 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
22 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Share Cafe Webinar - Potency assay data was in place for GvHD trial
|
|
scorpiomo
|
15 |
4.4K |
3 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
15
|
4.4K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Share Cafe Webinar - Potency assay data was in place for GvHD trial
|
|
scorpiomo
|
15 |
4.4K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
15
|
4.4K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
scorpiomo
|
549 |
169K |
3 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
169K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
12 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Share Cafe Webinar - Potency assay data was in place for GvHD trial
|
|
scorpiomo
|
15 |
4.4K |
7 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
15
|
4.4K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
scorpiomo
|
549 |
169K |
2 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
169K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
scorpiomo
|
549 |
169K |
0 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
169K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
scorpiomo
|
536 |
197K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
536
|
197K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
29 Feb HY Conference Call Transcript
|
|
scorpiomo
|
23 |
7.8K |
4 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
23
|
7.8K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
29 Feb HY Conference Call Transcript
|
|
scorpiomo
|
23 |
7.8K |
0 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
23
|
7.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
scorpiomo
|
78 |
23K |
6 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
23K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
scorpiomo
|
5.0K |
2.4M |
2 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
2
|
|